(Q42980838)

12 November 2017

title

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C. (English)

1 reference

12 November 2017

10

1 reference

12 November 2017

V Di Marco

1

1 reference

12 November 2017

O Lo Iacono

2

1 reference

12 November 2017

C Cammà

3

1 reference

12 November 2017

P L Almasio

4

1 reference

12 November 2017

A Vaccaro

5

1 reference

12 November 2017

P Fuschi

6

1 reference

12 November 2017

M Giunta

7

1 reference

12 November 2017

C Fabiano

8

1 reference

12 November 2017

L Pagliaro

9

1 reference

12 November 2017

publication date

1 January 1997

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

51

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

17-24

1 reference

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Hepatitis C serotype and response to interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Fatal hepatic decompensation associated with interferon alfa. European concerted action on viral hepatitis (Eurohep)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Interferon for non-A, non-B chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

HCV genotypes in chronic hepatitis C and response to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199701%2951%3A1%3C17%3A%3AAID-JMV3%3E3.0.CO%3B2-V

10.1002/(SICI)1096-9071(199701)51:1<17::AID-JMV3>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference